Vertigo: A complication of interferon therapy in a patient with chronic hepatitis C

Basit Öğe Kaydı
dc.contributor.authorGoral V.
dc.contributor.authorMeric F.
dc.contributor.authorAluclu U.
dc.contributor.authorDuzen S.
dc.date.accessioned2024-04-24T18:44:00Z
dc.date.available2024-04-24T18:44:00Z
dc.date.issued2000
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe occurrence of vertigo in a 60-year-old male submitted to interferon therapy in the management of chronic hepatitis C would appear to suggest that vertigo could be a side-effect of the drug and that it should be immediately withdrawn in such cases.en_US
dc.identifier.endpage35en_US
dc.identifier.issn0950-5911
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-0033914758
dc.identifier.scopusqualityN/A
dc.identifier.startpage34en_US
dc.identifier.urihttps://hdl.handle.net/11468/24507
dc.identifier.volume13en_US
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.relation.ispartofGastroenterology International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic Hepatitis Cen_US
dc.subjectInterferonen_US
dc.subjectVertigoen_US
dc.titleVertigo: A complication of interferon therapy in a patient with chronic hepatitis Cen_US
dc.titleVertigo: A complication of interferon therapy in a patient with chronic hepatitis C
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu